The U.S. Food and Drug Administration said Thursday it has reached a final decision to fully withdraw approval of pre-term birth drug Makena and its generics, a full 12 years after it hit the market. The drug was approved using the agency’s accelerate approval pathway in 2011 as a way to reduce the risk of pre-term birth in women pregnant with one baby who had a history of spontaneous pre-term birth.
The drug was approved using the agency’s accelerate approval pathway in 2011 as a way to reduce the risk of pre-term birth in women pregnant with one baby who had a history of spontaneous pre-term birth.
I smell some up coming big big pharma litigation.
ایران آخرین اخبار, ایران سرفصلها
Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.
منبع: WOKVNews - 🏆 247. / 63 ادامه مطلب »
منبع: ksatnews - 🏆 442. / 53 ادامه مطلب »
منبع: WashTimes - 🏆 235. / 63 ادامه مطلب »